PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 32 filers reported holding PROFOUND MED CORP in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,612 | -19.8% | 182,413 | +2.3% | 0.00% | – |
| Q2 2023 | $2,320,230 | +40.7% | 178,342 | +0.5% | 0.00% | – |
| Q1 2023 | $1,649,347 | -15.6% | 177,540 | -1.0% | 0.00% | – |
| Q4 2022 | $1,953,372 | +175.1% | 179,373 | +2.1% | 0.00% | – |
| Q3 2022 | $710,000 | +25.7% | 175,600 | +126.6% | 0.00% | – |
| Q2 2022 | $565,000 | -20.0% | 77,500 | -1.1% | 0.00% | – |
| Q1 2022 | $706,000 | -16.4% | 78,378 | +4.2% | 0.00% | – |
| Q4 2021 | $844,000 | -33.9% | 75,186 | -13.8% | 0.00% | – |
| Q3 2021 | $1,277,000 | +55.5% | 87,228 | +73.8% | 0.00% | – |
| Q2 2021 | $821,000 | -33.5% | 50,186 | -18.1% | 0.00% | – |
| Q1 2021 | $1,234,000 | +13.2% | 61,271 | +15.6% | 0.00% | – |
| Q4 2020 | $1,090,000 | -5.5% | 52,997 | -19.0% | 0.00% | – |
| Q3 2020 | $1,154,000 | +69.0% | 65,404 | +62.3% | 0.00% | – |
| Q2 2020 | $683,000 | +103.9% | 40,286 | +17.2% | 0.00% | – |
| Q1 2020 | $335,000 | +487.7% | 34,386 | +558.4% | 0.00% | – |
| Q4 2019 | $57,000 | – | 5,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timelo Investment Management Inc. | 673,158 | $6,866,212 | 9.03% |
| Gagnon Advisors, LLC | 679,296 | $6,928,819 | 5.80% |
| GAGNON SECURITIES LLC | 1,582,166 | $16,138,093 | 4.04% |
| THOMPSON DAVIS & CO., INC. | 86,375 | $881,025 | 1.09% |
| LETKO, BROSSEAU & ASSOCIATES INC | 1,164,125 | $11,352,296 | 0.22% |
| Zweig-DiMenna Associates LLC | 87,274 | $890,195 | 0.10% |
| MTM Investment Management, LLC | 19,875 | $202,725 | 0.10% |
| ROYCE & ASSOCIATES LP | 569,898 | $5,714,714 | 0.06% |
| Harbor Advisors LLC | 12,400 | $126,480 | 0.03% |
| FIL Ltd | 1,200,635 | $12,039,498 | 0.01% |